top of page
Date.png
PLASMA logo.png

In collaboration with

logo Saudi Myeloma Working Group.png

About PLASMA 2026

PLASMA 2026 is a CME-accredited masterclass designed to bring the most impactful global innovations in multiple myeloma directly to the Gulf.

 

The first edition will be held in Abu Dhabi on 6–7 February 2026, with the long-term goal of establishing PLASMA as a rotating regional initiative, hosted in different Gulf cities to ensure inclusivity and accessibility for healthcare professionals across the region.

Our Purpose

PLASMA was created to:

  • Distill the most practice-changing scientific updates and make them directly applicable to clinical practice in the Gulf.

  • Empower regional specialists by fostering collaboration with world-renowned experts.

  • Advance patient care by aligning global knowledge with local needs.

Scientific Backbone: MEMAC

PLASMA is supported by MEMAC – Middle East Masterclass in Hematology, a recognized educational platform and by the International Academy for Clinical Hematology (www.iach.org).

 

MEMAC delivers high-quality CME-accredited programs across the Middle East, validated by the European Board of Accreditation in Hematology (EBAH). By aligning with MEMAC, PLASMA ensures scientific credibility, regional relevance, and global recognition.

IACH supporting PLASMA
MEMAC supporting PLASMA

Collaboration with the Saudi Myeloma Working Group

We are proud to announce the official collaboration between PLASMA Masterclass and the Saudi Myeloma Working Group (SMWG), the leading national body driving clinical excellence and standardization of care for multiple myeloma in Saudi Arabia.

As part of this partnership, SMWG experts will deliver a dedicated session during PLASMA 2026, presenting their national recommendations and sharing key insights from real-world practice across the Kingdom.

This collaboration reinforces PLASMA’s mission to foster regional scientific exchange and to bridge international evidence with local expertise, ensuring that the Gulf’s evolving myeloma landscape is represented at the highest educational level.

Together, PLASMA and the SMWG aim to advance best practices in multiple myeloma management and strengthen cross-country collaboration throughout the region.

logo Saudi Myeloma Working Group.png

Leadership

  • Chairman: Prof. Mohamad Mohty (Paris, France)

  • Scientific & Communications Lead: Yasmina Salem (Founder, MyAdvisor, Dubai)

  • Co-organizer: Dr. Marika Crohns (Founder, IIMC, Dubai)

 

Together, the leadership team combines scientific excellence and communications expertise to deliver an event of international standards, tailored to the Gulf region.

Accreditation

PLASMA 2026 will be CME-accredited by EBAH, ensuring participants benefit from top-quality educational content aligned with global standards.

PLASMA accredited by EBAH
bottom of page